• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts.

作者信息

Ma S Y, Röyttä M, Rinne J O, Collan Y, Rinne U K

机构信息

Department of Neurology, University of Turku, Finland.

出版信息

J Neurol Sci. 1997 Oct 3;151(1):83-7. doi: 10.1016/s0022-510x(97)00100-7.

DOI:10.1016/s0022-510x(97)00100-7
PMID:9335015
Abstract

Previous studies based on single sections have suggested a significant correlation between pigmented neuronal loss in the substantia nigra (SN) and clinical features in Parkinson's disease (PD). However, disector (DS) counts-unbiased and accurate stereological estimates have not been available. To evaluate total neuron numbers in the pars compacta of the substantia nigra (SNpc) in relation to clinical features, we estimated the neuron counts in the SNpc by the DS method in brain samples from 12 controls and 12 PD patients. The total number of pigmented neurons in the whole SNpc was significantly reduced in PD patients (to 45% of the control mean, P < 0.001). The density of pigmented neurons (neuron/mm3) was reduced to 51% of the average control value (P < 0.001). No significant difference was seen in the volume (mm3) of the SNpc between PD patients and controls. Furthermore, the total number of pigmented neurons in the SNpc showed a significant negative correlation with the duration of disease (r = -0.86, P < 0.001) and with the stage of disease (r = -0.58, P < 0.05) in PD patients. Using an unbiased neuron counting method, these relationships, for the first time, demonstrate that the more severe pigmented neuronal loss in the SNpc is associated with the longer duration and the more severe stage of disease in PD patients.

摘要

相似文献

1
Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts.
J Neurol Sci. 1997 Oct 3;151(1):83-7. doi: 10.1016/s0022-510x(97)00100-7.
2
Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease.
Neuropathol Appl Neurobiol. 1995 Aug;21(4):341-3. doi: 10.1111/j.1365-2990.1995.tb01068.x.
3
Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls.
Neuropathol Appl Neurobiol. 1995 Feb;21(1):10-7. doi: 10.1111/j.1365-2990.1995.tb01023.x.
4
The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.采用无偏倚立体学方法估计正常受试者和帕金森病患者黑质中神经细胞的绝对数量。
J Neurol Neurosurg Psychiatry. 1991 Jan;54(1):30-3. doi: 10.1136/jnnp.54.1.30.
5
Unbiased morphological measurements show no neuronal loss in the substantia nigra in Alzheimer's disease.
Acta Neuropathol. 2002 Jan;103(1):43-7. doi: 10.1007/s004010100425.
6
A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease.帕金森病黑质神经元变性的定量形态学研究。
J Neurol Sci. 1996 Sep 1;140(1-2):40-5. doi: 10.1016/0022-510x(96)00069-x.
7
Marinesco bodies and substantia nigra neuron density in Parkinson's disease. Marinesco bodies 和帕金森病黑质神经元密度。
Neuropathol Appl Neurobiol. 2017 Dec;43(7):621-630. doi: 10.1111/nan.12419. Epub 2017 Jul 9.
8
Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.帕金森病黑质中脑源性神经营养因子信使核糖核酸表达降低。
Exp Neurol. 2000 Nov;166(1):127-35. doi: 10.1006/exnr.2000.7483.
9
Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea.帕金森病和亨廷顿舞蹈病中基底神经节和黑质的免疫细胞化学研究。
Neuroscience. 1988 May;25(2):419-38. doi: 10.1016/0306-4522(88)90249-7.
10
Increased iron-deposition in lateral-ventral substantia nigra pars compacta: A promising neuroimaging marker for Parkinson's disease.黑质致密部外侧腹侧铁沉积增加:帕金森病有前景的神经影像学标志物。
Neuroimage Clin. 2020;28:102391. doi: 10.1016/j.nicl.2020.102391. Epub 2020 Aug 20.

引用本文的文献

1
Understanding the progression of Parkinson's disease: a review.了解帕金森病的进展:综述
BMJ Neurol Open. 2025 Sep 8;7(2):e001215. doi: 10.1136/bmjno-2025-001215. eCollection 2025.
2
Integrated evaluation of Nigrosome 1 sign, neuromelanin-sensitive MR and iron deposition.黑质小体1征、神经黑色素敏感磁共振成像与铁沉积的综合评估
Jpn J Radiol. 2025 Aug 18. doi: 10.1007/s11604-025-01858-7.
3
Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor function.
向大鼠脑内纹状体注射α-突触核蛋白原纤维会导致左旋多巴可逆性感觉运动障碍和非运动功能改变。
Front Neurosci. 2025 Apr 1;19:1556447. doi: 10.3389/fnins.2025.1556447. eCollection 2025.
4
Levodopa treatment: impacts and mechanisms throughout Parkinson's disease progression.左旋多巴治疗:贯穿帕金森病进展过程中的影响及机制。
J Neural Transm (Vienna). 2025 Apr 11. doi: 10.1007/s00702-025-02893-4.
5
Exploring role of citrus fruits in comorbid neurodegenerative disorders associated with psoriasis.探索柑橘类水果在与银屑病相关的共病神经退行性疾病中的作用。
Metab Brain Dis. 2024 Dec 13;40(1):62. doi: 10.1007/s11011-024-01479-5.
6
Rate of motor progression in Parkinson's disease: a systematic review and meta-analysis.帕金森病运动进展率:一项系统评价与荟萃分析
Front Neurol. 2024 Sep 26;15:1452741. doi: 10.3389/fneur.2024.1452741. eCollection 2024.
7
Rodent Models of Alzheimer's Disease: Past Misconceptions and Future Prospects.阿尔茨海默病的啮齿动物模型:过去的误解和未来的前景。
Int J Mol Sci. 2024 Jun 5;25(11):6222. doi: 10.3390/ijms25116222.
8
Continuous long-range measurement of tonic dopamine with advanced FSCV for pharmacodynamic analysis of levodopa-induced dyskinesia in Parkinson's disease.利用先进的快速扫描循环伏安法对帕金森病左旋多巴诱导的异动症进行药效学分析时对多巴胺张力进行连续远程测量。
Front Bioeng Biotechnol. 2024 Jan 24;12:1335474. doi: 10.3389/fbioe.2024.1335474. eCollection 2024.
9
Initial Molecular Mechanisms of the Pathogenesis of Parkinson's Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease.帕金森病最早临床前期阶段小鼠神经毒性模型中帕金森病发病的初始分子机制
Int J Mol Sci. 2024 Jan 22;25(2):1354. doi: 10.3390/ijms25021354.
10
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils.用预形成原纤维诱导的大鼠早期突触核蛋白病的转录组分析。
NPJ Parkinsons Dis. 2024 Jan 3;10(1):7. doi: 10.1038/s41531-023-00620-y.